Clinical Trials Browser

Phase 1 × HER2-Positive Solid Tumors × Injections × Clear all

NCT04189211 2019-12-06

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

Phase 1 Unknown

Other solid neoplasm

HER2-Positive Solid Tumors